Your browser doesn't support javascript.
loading
Correction to: Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies.
Wynne, Chris; Balgos, Abundio; Li, Jingxin; Hamilton, Paul; Tirador, Louie; Jaen, Anjuli May; Mo, Chen; Yue, Zijing; Ma, Ying; Wang, Qingshuang; Wen, Rendu; Yao, Zheng; Yu, Jiaping; Yao, Wenrong; Zhang, Jianhui; Zheng, Hui; Hong, Kunxue; Zhu, Fengcai; Liu, Yong.
Afiliação
  • Wynne C; New Zealand Clinical Research, Christchurch, New Zealand.
  • Balgos A; Philippines Clinical Research, The Health Centrum, Roxas City, Philippines.
  • Li J; NHC Key Laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Nanjing, China.
  • Hamilton P; New Zealand Clinical Research, Auckland, New Zealand.
  • Tirador L; Philippines Clinical Research, St. Paul's Hospital, Iloilo City, Philippines.
  • Jaen AM; Philippines Clinical Research, The Medical City Iloilo, Iloilo City, Philippines.
  • Mo C; Jiangsu Recbio Technology Co., Ltd., Taizhou, China.
  • Yue Z; Jiangsu Recbio Technology Co., Ltd., Taizhou, China.
  • Ma Y; Jiangsu Recbio Technology Co., Ltd., Taizhou, China.
  • Wang Q; Jiangsu Recbio Technology Co., Ltd., Taizhou, China.
  • Wen R; Jiangsu Recbio Technology Co., Ltd., Taizhou, China.
  • Yao Z; Jiangsu Recbio Technology Co., Ltd., Taizhou, China.
  • Yu J; Jiangsu Recbio Technology Co., Ltd., Taizhou, China.
  • Yao W; Jiangsu Recbio Technology Co., Ltd., Taizhou, China.
  • Zhang J; Jiangsu Recbio Technology Co., Ltd., Taizhou, China.
  • Zheng H; School of Public Health, Southeast University, Nanjing, Jiangsu, People's Republic of China.
  • Hong K; Jiangsu Recbio Technology Co., Ltd., Taizhou, China.
  • Zhu F; NHC Key Laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Nanjing, China. jszfc@vip.sina.com.
  • Liu Y; School of Public Health, Southeast University, Nanjing, Jiangsu, People's Republic of China. jszfc@vip.sina.com.
Infect Dis Ther ; 13(7): 1723-1724, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38874695
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Infect Dis Ther Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Nova Zelândia País de publicação: Nova Zelândia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Infect Dis Ther Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Nova Zelândia País de publicação: Nova Zelândia